This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Investor Alert: Upcoming Deadlines In Shareholder Litigation Involving Teva Pharmaceuticals And Tri-Tech Holdings, Inc.

Holzer & Holzer reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Teva Pharmaceuticals Industries Limited and Tri-Tech Holdings, Inc.

Teva Pharmaceuticals Industries Limited

A class action lawsuit has been filed on behalf of investors who purchased Teva (NYSE: TEVA) securities between January 1, 2012 and October 29, 2013. The complaint alleges, among other things, that Teva made false and misleading statements to investors during that time that failed to disclose significant disagreements between the company’s board of directors and senior management. On October 30, 2013, Teva’s CEO and President, Dr. Jeremy Levin, announced his resignation from the company sending the price of Teva stock down significantly.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Southern District of New York, is February 24, 2014.

If you purchased shares between January 1, 2012 and October 29, 2013 and would like more information about your rights, please contact the firm or visit www.holzerlaw.com.

Tri-Tech Holdings, Inc.

A class action lawsuit has been filed on behalf of investors who purchased Tri-Tech Holdings (NASDAQ: TRIT) securities between March 26, 2012 and December 12, 2013 alleging the company violated the federal securities laws by issuing false and misleading statements to investors. According to the complaint, the company lacked adequate internal controls rendering certain of its statements made during that time misleading. On December 12, 2013, it was revealed that the company’s former Chief Executive Officer was terminated due to alleged violations of the company’s policies on wire transfers and the Nasdaq halted trading of TRIT following an 11% decline in share price.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Southern District of New York, is February 18, 2014. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Investors Are Encouraged To Contact The Firm

Investors that suffered significant losses investing in either of these companies during the specified times who are interested in potentially serving as lead plaintiff in the respective class actions are encouraged to contact Marshall P. Dees, Esq. by email at mdees@holzerlaw.com or via toll-free telephone at (888) 508-6832 to discuss their legal rights.

A lead plaintiff is a representative party appointed by the court to act on behalf of other class members in directing the litigation. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,039.49 +60.36 0.36%
S&P 500 1,992.37 +5.86 0.30%
NASDAQ 4,532.1040 +5.6220 0.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs